GlobeNewswire Inc | May 28, 2021 08:30AM EDT

May 28, 2021

CAMBRIDGE, Mass., May 28, 2021 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd.(Nasdaq: WVE), a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battling devastating diseases, announced today thatPaul Bolno, MD, MBA, President and Chief Executive Officer, is scheduled to give a presentation at the Jefferies Virtual Healthcare Conference onWednesday, June 2, 2021at11:30 a.m. ET. Dr. Bolno will provide a corporate update and discuss Waves pipeline programs, including the first in vivo data from the companys ADAR editing discovery program for alpha-1 antitrypsin deficiency (AATD).

A live webcast of the presentation will be available on the investor relations page of theWave Life Sciencescorporate website at http://ir.wavelifesciences.com.A replay of the presentation will be archived and available at that site for 90 days following the event.

AboutWave Life SciencesWave Life Sciences(Nasdaq: WVE) is a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battling devastating diseases. Wave aspires to develop best-in-class medicines across multiple therapeutic modalities using PRISM, the companys proprietary discovery and drug development platform that enables the precise design, optimization and production of stereopure oligonucleotides. Driven by a resolute sense of urgency, the Wave team is targeting a broad range of genetically defined diseases so that patients and families may realize a brighter future. To find out more, please visitwww.wavelifesciences.comand follow Wave on Twitter @WaveLifeSci.

Investor Contact:Kate Rausch617-949-4827krausch@wavelifesci.com

Media Contact:Alicia Suter617-949-4817asuter@wavelifesci.com